Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Cancer Immunotherapy
... CAGR of 13.7% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$266.2 Billion by the end of the analysis ... Read More
-
Genomics in Cancer Care
... 2030, growing at a CAGR of 16.7% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$25.0 Billion by the end ... Read More
-
Cancer Gene Therapy
... at a CAGR of 20.9% over the analysis period 2024-2030. Oncolytic Virotherapy, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$4.3 Billion by the end of ... Read More
-
Cancer / Tumor Profiling
... 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. Immunoassays, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$6.7 Billion by the end ... Read More
-
Tumor / Cancer Markers
... 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 10.4% CAGR The Tumor / Cancer Markers market ... Read More
-
Cancer Stem Cells
... at a CAGR of 8.5% over the analysis period 2024-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.3 Billion by the ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach ... Read More
-
Cancer Supportive Care Drugs Global Market Report 2025
... care drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Multiple Myeloma - Market Insight, Epidemiology, and Market Forecast - 2034
... incident cases, label expansion and penetration of current therapies in earlier lines, high adoption of newer therapies mainly CAR-T cell therapies and anti-BCMA, rich emerging pipeline, and expected increase in investment in the R&D activities ... Read More
-
Gynecological Cancer Drugs
... at a CAGR of 5.1% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$12.1 Billion by the end of ... Read More
-
Chronic Myelogenous Leukemia Treatment
... 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Disease Specific Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.4 Billion by ... Read More
-
Leukemia Therapeutics
... CAGR of 5.6% over the analysis period 2024-2030. Chronic Myeloid Leukemia, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$9.1 Billion by the end of the ... Read More
-
Oncology Information Systems
... at a CAGR of 6.2% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$5.5 Billion by the end of the ... Read More
-
Cancer Care (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Cancer Care (UK) report will tell you the companies that have ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025
... immunotherapy drug discovery outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Women's Health Diagnostics Market Report by Type (Diagnostic Devices, Diagnostic Tests), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, and Others), End User (Hospital and Diagnostics Centers, Home Care), and Region 2025-2033
... 2025-2033. The market is propelled by the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments in diagnostic services, increasing awareness about women’s health through numerous campaigns and initiatives by the ... Read More
-
Refractory Metastatic Melanoma - Pipeline Insight, 2025
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Refractory Metastatic Melanoma: ... Read More
-
2025 Global Gene Therapy For Cancer Market Industry (2031 Outlook)
... data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, ... Read More
-
Squamous Non-Small Cell Lung Cancer - Global Clinical Trials Review, 2025
... Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Squamous Non-Small Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Virtual Oncology Market, By Component (Software, Service, Hardware), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Others (Pancreatic, Ovarian, etc.)), By Application (Precision Medicine, Patient Care Management, Research & Development, Clinical Trials, Diagnosis & Treatment Decision Making, Data Management, Others (Billing Management, Regulatory Compliance etc.)), By End User (Hospitals & Diagnostic Imaging Centers, Academic Institutions & Research Centers, Pharma & Biotech Companies, Contract Research Organizations (CROs), Others (Reference Laboratories, Pharmacies etc.)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... The aim of virtual oncology is to improve patient outcomes, increase access to care, and enhance the overall patient experience. With advancements in technology and the increasing prevalence of cancer worldwide, virtual oncology has gained ... Read More
-
Fecal Calprotectin Test Market, By Assay Type (Enzyme Linked Immunosorbent Assay (ELISA), Enzyme Fluoroimmunoassay, and Quantitative Immune-Chromatography), By Indication (Inflammatory Bowel Disease (IBD) Diagnosis, Colorectal Cancer, Celiac Disease, and others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and others), , By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... making it a helpful biomarker for identifying and tracking the condition. Market Dynamics: The increasing prevalence of gastrointestinal disorders, growing awareness and early detection, and non-invasive and convenient testing are anticipated to drive growth of ... Read More
-
Genomic Cancer Testing Market, By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Immunohistochemistry, Other genomic testing technologies), By End-User (Hospitals, Diagnostic Laboratories, Academic and Research Institutions, Cancer Centers, Other healthcare providers), By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Molecular Biomarkers, Epigenetic Biomarkers), By Service Provider (Diagnostic Laboratories, Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations), By Application (Targeted Therapy Selection, Disease Monitoring, Prognostic Testing, Companion Diagno
... tailor treatment based on an individual’s genetic profile and select therapeutics that directly target the abnormalities present. The genomic analysis of a tumor helps predict response to certain drugs, checks for genetic markers that may ... Read More
-
Physician Office Diagnostic Market, By Product Type (Point-of-Care Testing (POCT) Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, and Urinalysis Systems), By End User (Physician Offices and Clinics, Urgent Care Centers, and Ambulatory Care Centers), By Application (Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Cancer Diagnosis, Pregnancy and Fertility Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... are anticipated to drive growth of the global physician office diagnostic market over the forecast period. Moreover, increasing focus on personalized medicine is also expected to boost growth of the global physician office diagnostic market ... Read More
-
Genomic Cancer Panel and Profiling Market - A Global and Regional Analysis: Focus on Tissue Testing, Cancer Panel Type, Cancer Type, Application, Technology, End User, and Region - Analysis and Forecast, 2025-2035
... prevalence of cancer worldwide, coupled with the growing demand for personalized treatment approaches, has accelerated the adoption of genomic cancer panels for early diagnosis, prognosis, and therapy selection. According to the data published by the ... Read More
-
Canada Clinical Nutrition Market, By Nutrition Type (Enteral Nutrition (Standard Nutrition, Disease Specific Nutrition), Parenteral Nutrition (Amino Acid, Carbohydrates, Vitamins and Minerals, Others (Proteins, Lipids among Others))), By Form (Powder, Liquid, Tablets, Capsules, Gummies, Others (Nutrition Bar, among Others)), By Route of Administration (Oral, Enteral, Parenteral), By Age Group (Infant Nutrition, Adult Nutrition, Geriatric Nutrition), By Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, Other (Cardiovascular Diseases and Others)), By End User (Hospitals, Ambulatory Surgical Centers, Long Term Care Facilities)
... plays an important role in the human body, deficiency of essential nutrients could lead to various problems, such as anemia, diabetes, and blood disorder. Clinical nutrition products help to improve metabolism, digestion, absorption, and storage ... Read More
Research Assistance
